Company intelligence / Profile preview

AB-CT

Erlangen, Bavaria, Germanyab-ct.com ↗

Ownership: Private
Development stage: Commercial

Overview

nu:view is CE marked and commercially available in certain regions. It is the world’s first spiral breast CT scanner using photon-counting technology, providing high-resolution 3D images without compression and at low radiation dose. The device is designed for improved patient comfort and early, reliable diagnosis of breast cancer. Clinical integration with RIS & PACS has been achieved; no published clinical trial results are referenced.

Therapeutic areas: Oncology
Modalities: Device (Breast CT scanner)
Industry: Medical Imaging

Beyond the preview

Go deeper on AB-CT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AB-CT.

Explore the full profile